Busulfan, Fludarabine, and Alemtuzumab Conditioning and Unrelated Cord Blood Transplantation in Children with Sickle Cell Disease

Authors

Kavita Radhakrishnan
Monica Bhatia
Mark B. Geyer
Gustavo Del Toro
Zhezhen Jin
Courtney Baker
Lauren Harrison
Erin Morris
Lee Ann Baxter-Lowe
Mitchell Cairo, New York Medical CollegeFollow

Author Type(s)

Faculty

DOI

10.1016/j.bbmt.2013.02.002

Journal Title

Biology of Blood and Marrow Transplantation

First Page

676

Last Page

677

Document Type

Article

Publication Date

4-1-2013

Department

Pediatrics

Keywords

Alemtuzumab, Anemia, Sickle Cell, Antibodies, Monoclonal, Humanized, Busulfan, Child, Child, Preschool, Cord Blood Stem Cell Transplantation, Female, Graft Rejection, Graft Survival, Humans, Infant, Male, Myeloablative Agonists, Transplantation Conditioning, Unrelated Donors, Vidarabine

Disciplines

Medicine and Health Sciences

Recommended Citation

Radhakrishnan, K., Bhatia, M., Geyer, M. B., Del Toro, G., Jin, Z., Baker, C., Harrison, L., Morris, E., Baxter-Lowe, L., & Cairo, M. (2013). Busulfan, Fludarabine, and Alemtuzumab Conditioning and Unrelated Cord Blood Transplantation in Children with Sickle Cell Disease. Biology of Blood and Marrow Transplantation, 19 (4), 676-677. https://doi.org/10.1016/j.bbmt.2013.02.002